K. S. Tatishcheva
Research Subjects
K. S. Tatishcheva has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- I. A. Babenchuk
Skyfert Ltd., Reproductive Medicine Clinic, St. Petersburg, Russia
2 shared publications - Alla S. Kalugina
Academician I.P. Pavlov First Saint Petersburg State Medical University
1 shared publication - D. A. Gerkulov
«Skyfert» LLC
1 shared publication - D.A. Lobzeva
«Skyfert» LLC
1 shared publication - Faina M. Zakharova
Institute of Experimental Medicine
1 shared publication - Natalya A. Kuzminykh
Skyfert Ltd., Reproductive Medicine Clinic, St. Petersburg, Russia
1 shared publication
Latest Publications
- 16 September 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (4)
Ability of using granulocyte colony-stimulating factor in reproductive medicine
Assuming the increasing infertility frequency in many developed countries, connected both to a growing anthropogenic factor influence and sustained tendency of reproductive plans realization’s postponement for advanced years, this review is dedicated to the pressing problem in modern medicine: increasing the ART program’s efficacy in patients with the recurrent implantation failures. In this regard, the role of G-KSF in a regulation of ovarian functioning, folliculogenesis, ovulation, oocyte competence’s formation has been covered in detail. There is a distinct part in the article devoted to a role of G-KSF in a process of embryo implantation within the natural pregnancy and ART programs. According to the numerous scientific data related to G-KSF, it has a direct regulatory effect on the main processes associated with the reproductive function’s implementation such as oocyte maturation, process of ovulation, fertilization and embryo development, trophoblast invasion as well as the placentation support. The potential of a clinical use of G-KSF medication in different groups of patients with infertility is considered. There’re results of randomized and cohort studies aimed at efficacy and safety of use presented. It seems highly promising the realization of such medications in order to increase ART efficacy, especially in cases with the repeated implantation failures and advanced reproductive aged groups.
- 16 September 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (4)
Ability of using granulocyte colony-stimulating factor in reproductive medicine
Assuming the increasing infertility frequency in many developed countries, connected both to a growing anthropogenic factor influence and sustained tendency of reproductive plans realization’s postponement for advanced years, this review is dedicated to the pressing problem in modern medicine: increasing the ART program’s efficacy in patients with the recurrent implantation failures. In this regard, the role of G-KSF in a regulation of ovarian functioning, folliculogenesis, ovulation, oocyte competence’s formation has been covered in detail. There is a distinct part in the article devoted to a role of G-KSF in a process of embryo implantation within the natural pregnancy and ART programs. According to the numerous scientific data related to G-KSF, it has a direct regulatory effect on the main processes associated with the reproductive function’s implementation such as oocyte maturation, process of ovulation, fertilization and embryo development, trophoblast invasion as well as the placentation support. The potential of a clinical use of G-KSF medication in different groups of patients with infertility is considered. There’re results of randomized and cohort studies aimed at efficacy and safety of use presented. It seems highly promising the realization of such medications in order to increase ART efficacy, especially in cases with the repeated implantation failures and advanced reproductive aged groups.
- 20 August 2026
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 20 (S2) , S219-S227
Morphometric Parameters of Oocyte-Cumulus Complexes as Predictive Factors for In Vitro Oocyte Maturation
Background: Advances in assisted reproductive technologies (ART) make it possible today not only to overcome many types of infertility, but also to preserve gametes or embryos prior to gonadotoxic treatment. In a number of cases, when urgent fertility preservation programs are required in women, immature oocyte-cumulus complexes (OCC) are retrieved with subsequent in vitro maturation (IVM). This method has become widespread across various clinical indications; however, its efficiency remains relatively low, requiring optimization of protocols and the study of factors influencing maturation. Objective: The aim of this study was to evaluate the relationship between the diameter of retrieved oocytes, the density of their cumulus cells, and the maturation rate in patients of different age groups. Methods: The study included two groups of patients: the OPU-IVM group, in which oocytes were obtained via transvaginal follicular aspiration, and the OTO-IVM group, where oocytes were harvested ex vivo from excised ovarian tissue. For all OCC, visual assessment of cumulus volume, structure, and density was performed, alongside measurement of the mean oocyte diameter. Results: The overall maturation efficiency to the MII stage was 50.6% in the OPU-IVM group and 37.0% in the OTO-IVM group. Oocytes that successfully matured to the MII stage had a significantly larger mean diameter (114.5 μm) compared to those that arrested in development (111.8 μm). The presence of a “compact” cumulus was associated with a high MII maturation rate, whereas OCC categorized as “sparse cumulus” or “denuded/absent cumulus” accounted for the main proportion of degenerated oocytes. Conclusion: The obtained data allow for an objective assessment of the prospects of immature oocyte culture derived from OPU-IVM and OTO-IVM programs.
- 20 August 2026
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 20 (S2) , S219-S227
Morphometric Parameters of Oocyte-Cumulus Complexes as Predictive Factors for In Vitro Oocyte Maturation
Background: Advances in assisted reproductive technologies (ART) make it possible today not only to overcome many types of infertility, but also to preserve gametes or embryos prior to gonadotoxic treatment. In a number of cases, when urgent fertility preservation programs are required in women, immature oocyte-cumulus complexes (OCC) are retrieved with subsequent in vitro maturation (IVM). This method has become widespread across various clinical indications; however, its efficiency remains relatively low, requiring optimization of protocols and the study of factors influencing maturation. Objective: The aim of this study was to evaluate the relationship between the diameter of retrieved oocytes, the density of their cumulus cells, and the maturation rate in patients of different age groups. Methods: The study included two groups of patients: the OPU-IVM group, in which oocytes were obtained via transvaginal follicular aspiration, and the OTO-IVM group, where oocytes were harvested ex vivo from excised ovarian tissue. For all OCC, visual assessment of cumulus volume, structure, and density was performed, alongside measurement of the mean oocyte diameter. Results: The overall maturation efficiency to the MII stage was 50.6% in the OPU-IVM group and 37.0% in the OTO-IVM group. Oocytes that successfully matured to the MII stage had a significantly larger mean diameter (114.5 μm) compared to those that arrested in development (111.8 μm). The presence of a “compact” cumulus was associated with a high MII maturation rate, whereas OCC categorized as “sparse cumulus” or “denuded/absent cumulus” accounted for the main proportion of degenerated oocytes. Conclusion: The obtained data allow for an objective assessment of the prospects of immature oocyte culture derived from OPU-IVM and OTO-IVM programs.